Nikko Asset Management Americas, Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2020. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$35,422,523
-12.0%
1,388,574
-1.2%
0.42%
-0.2%
Q2 2023$40,251,302
+22.1%
1,404,932
-1.1%
0.42%
+11.6%
Q1 2023$32,967,507
+34.2%
1,420,401
-2.0%
0.38%
+7.3%
Q4 2022$24,561,567
+16.1%
1,449,060
-0.7%
0.35%
+31.1%
Q3 2022$21,162,000
+17.9%
1,459,415
+1.6%
0.27%
+21.6%
Q2 2022$17,952,000
-52.6%
1,436,194
+2.4%
0.22%
-20.1%
Q1 2022$37,856,000
-20.8%
1,402,078
+3.3%
0.28%
+10.8%
Q4 2021$47,783,000
-23.5%
1,357,472
-0.1%
0.25%
-6.3%
Q3 2021$62,492,000
+51.7%
1,358,532
+11.8%
0.27%
+66.5%
Q2 2021$41,185,000
+215.8%
1,214,901
+284.7%
0.16%
+151.6%
Q1 2021$13,043,000
+8.3%
315,812
+13.7%
0.06%
-5.9%
Q4 2020$12,046,000
+114.1%
277,686
+111.7%
0.07%
+36.0%
Q3 2020$5,627,000
-14.2%
131,170
-8.6%
0.05%
-41.9%
Q2 2020$6,559,000
-5.4%
143,487
-71.9%
0.09%
+32.3%
Q1 2020$6,932,000
+127.3%
510,132
+81.8%
0.06%
+35.4%
Q4 2019$3,050,000
-0.5%
280,548
-6.0%
0.05%
-11.1%
Q3 2019$3,066,000
+149.9%
298,530
+129.7%
0.05%
+125.0%
Q2 2019$1,227,000129,9740.02%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2020
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders